Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LEGN - Legend Biotech Corp - ADR


IEX Last Trade
57.54
0.830   1.442%

Share volume: 561,890
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$56.71
0.83
1.46%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0.09%
1 Month
1.23%
3 Months
32.82%
6 Months
-15.09%
1 Year
-17.29%
2 Year
29.50%
Key data
Stock price
$57.54
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$38.60 - $71.68
52 WEEK CHANGE
-$0.20
MARKET CAP 
10.492 B
YIELD 
N/A
SHARES OUTSTANDING 
182.305 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/20/2024
BETA 
0.70
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$435,695
AVERAGE 30 VOLUME 
$626,071
Company detail
CEO:
Region: US
Website:
Employees: 836
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

legend biotech corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. teamed up with outstanding immunologists and molecular biologists, legend has generated a strong pipeline of chimeric antigen receptor(car) product candidates to treat a wide variety of liquid and solid tumors. our ambition to succeed in the cars field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. by applying one of our proprietary car-t technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. legend biotech corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. we take o

Recent news